Promimic AB (publ) (STO:PRO)
10.00
0.00 (0.00%)
Jul 24, 2026, 2:21 PM CET
Promimic AB Revenue
Promimic AB had revenue of 9.49M SEK in the quarter ending March 31, 2026, a decrease of -13.54%. This brings the company's revenue in the last twelve months to 51.25M, up 0.68% year-over-year. In the year 2025, Promimic AB had annual revenue of 52.73M with 6.84% growth.
Revenue (ttm)
51.25M
Revenue Growth
+0.68%
P/S Ratio
3.79
Revenue / Employee
2.77M
Employees
18
Market Cap
188.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.73M | 3.37M | 6.84% |
| Dec 31, 2024 | 49.36M | 9.23M | 23.00% |
| Dec 31, 2023 | 40.13M | 22.42M | 126.64% |
| Dec 31, 2022 | 17.71M | 9.28M | 110.16% |
| Dec 31, 2021 | 8.43M | 2.13M | 33.84% |
| Dec 31, 2020 | 6.30M | 478.00K | 8.22% |
| Dec 31, 2019 | 5.82M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 461.29M |
| Arcoma AB | 127.06M |
| Integrum AB | 96.14M |
| SciBase Holding AB | 45.88M |
| BrainCool AB | 44.02M |
| Ortoma AB | 42.65M |
| Nosa Plugs AB | 27.87M |
| Episurf Medical AB | 26.10M |
Promimic AB News
- 2 months ago - Promimic AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Promimic AB Annual report: Q4 2025 - Filings
- 5 months ago - Promimic AB Quarterly report: Q4 2025 - Filings
- 8 months ago - Promimic AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Promimic AB Quarterly report: Q2 2025 - Filings